Insilicotrials joins microsoft for startups pegasus program to accelerate digital transformation in healthcare

Wilmington, del.--(business wire)--insilicotrials, a health tech company developing simulation-based solutions for drug development, today announced its acceptance into the microsoft for startups pegasus program, an, invitation-only initiative within microsoft for startups, designed to accelerate the growth of high-potential startups. this milestone marks a significant step in insilicotrials' mission to modernize healthcare r&d through ai and in silico simulation technologies. the microsoft.
MSFT Ratings Summary
MSFT Quant Ranking